Skip to main content
WeightCited

Berberine के लिए Metabolic Syndrome

A संबंधित साक्ष्य कई बड़े नैदानिक परीक्षण लगातार महत्वपूर्ण लाभ दर्शाते हैं।

Meta-analysis of 12 RCTs (n=1,068) found significant reductions in body weight (2.07 kg), BMI, waist circumference, and triglycerides. Berberine addresses multiple metabolic syndrome components simultaneously through AMPK activation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dmetabolic\u002Dsyndrome'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

निष्कर्ष

Meta-analysis of 12 RCTs (n=1,068) found significant reductions in body weight (2.07 kg), BMI, waist circumference, and triglycerides. Berberine addresses multiple metabolic syndrome components simultaneously through AMPK activation.

Key Study Findings

Other 6 weeks
Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila.
Dose: None बनाम: MCD diet MASH model; Abx + FMT experiments Outcome: Hepatic/colonic inflammation, Akkermansia abundance प्रभाव: None None

जनसंख्या: MCD diet-induced MASH C57BL/6J male mice

Other
The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with …
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

Systematic Review n=61
Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: Alzheimer's disease patients

Key Statistics

12

अध्ययन

1068

प्रतिभागी

Positive

A

ग्रेड

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
500 mg 2-3x/day with meals
starting:
500 mg/day and titrate
metabolicsupport:
1,000-1,500 mg/day

अधिकतम सीमा: 1,500 mg/day; GI side effects limit intake; potential drug interactions

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None 6 weeks Positive --
None -- Mixed --
None -- Positive 61

सेवन का सर्वोत्तम समय: With meals (reduces GI discomfort and synchronizes with postprandial glucose metabolism)

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Diarrhea
  • Constipation
  • Flatulence
  • Abdominal pain
  • Potential hypoglycemia (when combined with diabetes medications)

ज्ञात अंतःक्रियाएँ

  • Diabetes medications (may potentiate — hypoglycemia risk)
  • CYP3A4 substrates (berberine is a CYP3A4 inhibitor)
  • CYP2D6 substrates
  • Cyclosporine
  • Metformin (additive effects)

सहनीय अधिकतम सेवन: 1,500 mg/day; GI side effects limit intake; potential drug interactions

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Berberine help with Metabolic Syndrome?
Based on 12 studies with 1,068 participants, there is strong evidence from multiple clinical trials that Berberine may support Metabolic Syndrome management. Our evidence grade is A (Strong Evidence).
How much Berberine should I take for Metabolic Syndrome?
Studies have used various dosages. A commonly studied range is 500 mg 2-3x/day with meals. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Berberine?
Reported side effects may include Diarrhea, Constipation, Flatulence, Abdominal pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Berberine and Metabolic Syndrome?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 12 peer-reviewed studies with 1,068 total participants. The overall direction of effect is positive.

इसके लिए अन्य सामग्री Metabolic Syndrome

Berberine अन्य स्वास्थ्य स्थितियों के लिए

References

  1. [1] Jiahui Xu et al.. J Nutr Biochem. 2025. Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila. doi:10.1016/j.jnutbio.2025.110069 PubMed
  2. [2] Yufan Dai et al.. Braz J Med Biol Res. 2022. The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in … doi:10.1590/1414-431X2022e12096 PubMed
  3. [3] Noriko Shinjyo et al.. J Integr Med. 2020. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. doi:10.1016/j.joim.2020.01.004 PubMed

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।